George Buchman

Vice President, Pre-Clinical and Process Development • Catalent Cell and Gene Therapy

Buchman joined Catalent through its acquisition of Paragon Gene Therapy in 2019. He has more than 30 years of experience in the biotech industry and has held roles at companies including Life Technologies (now Thermo Fisher), Celera Genomics and GeneLogic. Dr. Buchman obtained a bachelor’s degree in biochemistry from Albright College, Reading, Pennsylvania, and a doctorate in biochemistry from University of Maryland.  

Also Speaking

Friedrich Graf Finckenstein

Chief Medical Officer • Iovance Biotherapeutics Inc

Brahm Goldstein

Vice President, Research and Development, Hematology • CSL Behring

Kristin Viswanathan Wolff

Vice President, Market Access  • bluebird bio

Also Speaking


Germfree Truck



Book your hotel room for your stay in Miami.